NO20021077L - Amino-triazolopyridin-derivater - Google Patents

Amino-triazolopyridin-derivater

Info

Publication number: NO20021077L
Authority: NO; Norway
Prior art keywords: triazolopyridin; derivatives; amino; triazolopyridin derivatives
Prior art date: 1999-09-06

Application number

NO20021077A

Other languages

English (en)

Other versions

NO20021077D0 (no

Inventor

Gerda Huber Trottmann

Walter Hunkeler

Roland Jakob-Roetne

Gavin John Kilpatrick

Matthias Heinrich Nettekoven

Claus Riemer

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-06

Filing date

2002-03-05

Publication date

2002-03-05

2002-03-05 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2002-03-05 Publication of NO20021077D0 publication Critical patent/NO20021077D0/no

2002-03-05 Publication of NO20021077L publication Critical patent/NO20021077L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Immunology (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO20021077A 1999-09-06 2002-03-05 Amino-triazolopyridin-derivater NO20021077L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99117578		1999-09-06
PCT/EP2000/008372 WO2001017999A2 (en)	1999-09-06	2000-08-28	Amino-triazolopyridine derivatives

Publications (2)

Publication Number	Publication Date
NO20021077D0 NO20021077D0 (no)	2002-03-05
NO20021077L true NO20021077L (no)	2002-03-05

Family

ID=8238933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20021077A NO20021077L (no)	1999-09-06	2002-03-05	Amino-triazolopyridin-derivater

Country Status (22)

Country	Link
US (1)	US6355653B1 (no)
EP (1)	EP1214322A2 (no)
JP (1)	JP2003528811A (no)
KR (1)	KR20020027625A (no)
CN (1)	CN1379777A (no)
AR (1)	AR037484A1 (no)
AU (1)	AU7511000A (no)
BR (1)	BR0013792A (no)
CA (1)	CA2383998A1 (no)
CZ (1)	CZ20021220A3 (no)
HR (1)	HRP20020172A2 (no)
HU (1)	HUP0203316A3 (no)
IL (1)	IL148167A0 (no)
MA (1)	MA26816A1 (no)
MX (1)	MXPA02001748A (no)
NO (1)	NO20021077L (no)
PE (1)	PE20010629A1 (no)
PL (1)	PL354240A1 (no)
TR (1)	TR200200579T2 (no)
WO (1)	WO2001017999A2 (no)
YU (1)	YU13502A (no)
ZA (1)	ZA200201055B (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6506772B1 (en)	2000-12-15	2003-01-14	Hoffmann-La Roche Inc.	Substituted [1,2,4]triazolo[1,5a]pyridine derivatives with activity as adenosine receptor ligands
US6514989B1 (en) *	2001-07-20	2003-02-04	Hoffmann-La Roche Inc.	Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives
US6693116B2 (en) *	2001-10-08	2004-02-17	Hoffmann-La Roche Inc.	Adenosine receptor ligands
PL370067A1 (en) *	2001-10-08	2005-05-16	F.Hoffmann-La Roche Ag	8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide
US6875772B2 (en)	2001-11-30	2005-04-05	Schering Corporation	[1,2,4]-Triazole bicyclic adeonsine A2a receptor antagonists
HUP0105407A3 (en) *	2001-12-21	2004-04-28	Sanofi Aventis	Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
AU2003207734C1 (en)	2002-01-28	2009-10-08	Kyowa Kirin Co., Ltd.	Methods of treating patients suffering from movement disorders
AU2003233127A1 (en) *	2002-06-13	2003-12-31	Pfizer Inc.	Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
WO2005070927A2 (en) *	2004-01-26	2005-08-04	Altana Pharma Ag	1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
JP2008524330A (ja)	2004-12-21	2008-07-10	シェーリングコーポレイション	ピラゾロ［１，５−Ａ］ピリミジンアデノシンＡ２ａ受容体アンタゴニスト
ES2273599B1 (es)	2005-10-14	2008-06-01	Universidad De Barcelona	Compuestos para el tratamiento de la fibrilacion auricular.
WO2008014199A2 (en) *	2006-07-28	2008-01-31	Boehringer Ingelheim International Gmbh	Sulfonyl compounds which modulate the cb2 receptor
JP5030114B2 (ja) *	2006-09-25	2012-09-19	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｂ２受容体をモジュレートする化合物
MX2009005478A (es) *	2006-11-27	2009-08-12	Lundbeck & Co As H	Derivados de heteroarilamida.
DE602007012133D1 (de) *	2006-12-01	2011-03-03	Andrew Burritt	Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
EP2592082A1 (en) *	2007-04-10	2013-05-15	H. Lundbeck A/S	Heteroaryl amide analogues as p2x7 antagonists
WO2009017954A1 (en) *	2007-08-01	2009-02-05	Phenomix Corporation	Inhibitors of jak2 kinase
GB0719803D0 (en)	2007-10-10	2007-11-21	Cancer Rec Tech Ltd	Therapeutic compounds and their use
WO2009061652A1 (en) *	2007-11-07	2009-05-14	Boehringer Ingelheim International Gmbh	Compounds which modulate the cb2 receptor
EP2418207A1 (en) *	2008-05-13	2012-02-15	Boehringer Ingelheim International GmbH	Sulfone compounds which modulate the CB2 receptor
PE20110063A1 (es) *	2008-06-20	2011-02-16	Genentech Inc	DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
CA2727036C (en) *	2008-06-20	2017-03-21	Genentech, Inc.	Triazolopyridine jak inhibitor compounds and methods
WO2010005782A1 (en) *	2008-07-10	2010-01-14	Boehringer Ingelheim International Gmbh	Sulfone compounds which modulate the cb2 receptor
TWI453207B (zh) *	2008-09-08	2014-09-21	Signal Pharm Llc	胺基三唑并吡啶，其組合物及使用其之治療方法
EP2342199B1 (en) *	2008-09-25	2014-02-26	Boehringer Ingelheim International GmbH	Sulfonyl compounds which selectively modulate the CB2 receptor
MY153913A (en) *	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
WO2010141796A2 (en)	2009-06-05	2010-12-09	Cephalon, Inc.	PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES
US8299103B2 (en) *	2009-06-15	2012-10-30	Boehringer Ingelheim International Gmbh	Compounds which selectively modulate the CB2 receptor
US8383615B2 (en)	2009-06-16	2013-02-26	Boehringer Ingelheim International Gmbh	Azetidine 2-carboxamide derivatives which modulate the CB2 receptor
US8283465B2 (en) *	2009-07-17	2012-10-09	Japan Tobacco Inc.	Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent
JP2013505295A (ja) *	2009-09-22	2013-02-14	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｂ２受容体を選択的に調節する化合物
WO2011088015A1 (en)	2010-01-15	2011-07-21	Boehringer Ingelheim International Gmbh	Compounds which modulate the cb2 receptor
US8329735B2 (en)	2010-03-05	2012-12-11	Boehringer Ingelheim International Gmbh	Tetrazole compounds which selectively modulate the CB2 receptor
US8846936B2 (en)	2010-07-22	2014-09-30	Boehringer Ingelheim International Gmbh	Sulfonyl compounds which modulate the CB2 receptor
BR112014006248A2 (pt) *	2011-09-19	2017-04-11	Hoffmann La Roche	compostos de triazolopiridina como inibidores de pde10a
WO2013043518A1 (en)	2011-09-22	2013-03-28	Merck Sharp & Dohme Corp.	Imidazopyridyl compounds as aldosterone synthase inhibitors
US9193724B2 (en) *	2011-09-22	2015-11-24	Merck Sharp & Dohme Corp.	Triazolopyridyl compounds as aldosterone synthase inhibitors
EP2803668A1 (en)	2013-05-17	2014-11-19	Boehringer Ingelheim International Gmbh	Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
EP3429997A1 (de)	2016-03-16	2019-01-23	Bayer CropScience Aktiengesellschaft	N-(cyanbenzyl)-6-(cyclopropylcarbonylamino)-4-(phenyl)-pyridin-2-carboxamid-derivate und verwandte verbindungen als pestizide pflanzenschutzmittel
CN106543175B (zh) *	2016-10-28	2018-06-01	上海大学	三芳基[1,2,4]三氮唑[1,5-a]吡啶衍生物及其制备方法
MX393395B (es) *	2017-03-16	2025-03-24	Jiangsu Hengrui Medicine Co	Derivado de heteroaril[4,3-c]pirimidina-5-amina, método de preparación del mismo y usos médicos del mismo.
WO2019168847A1 (en)	2018-02-27	2019-09-06	Incyte Corporation	Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors
CA3100731A1 (en)	2018-05-18	2019-11-21	Incyte Corporation	Fused pyrimidine derivatives as a2a / a2b inhibitors
SG11202013216RA (en) *	2018-07-05	2021-01-28	Incyte Corp	Fused pyrazine derivatives as a2a / a2b inhibitors
JP7399589B2 (ja) *	2018-09-12	2023-12-18	日本化薬株式会社	有害生物防除剤
MA54551A (fr)	2018-12-20	2021-10-27	Incyte Corp	Composés d'imidazopyridazine et d'imidazopyridine utilisés en tant qu'inhibiteurs de la kinase 2 de type récepteur de l'activine
TWI829857B (zh)	2019-01-29	2024-01-21	美商英塞特公司	作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
CA3172939A1 (en) *	2021-01-09	2022-07-14	Bugworks Research, Inc.	Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2a receptor and adenosine 2b receptor antagonist
CN116082335A (zh) *	2023-01-16	2023-05-09	上海凌凯医药科技有限公司	一种二芳基醚化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9226735D0 (en)	1992-12-22	1993-02-17	Ici Plc	Azole derivatives
AU2639299A (en)	1998-02-24	1999-09-15	Kyowa Hakko Kogyo Co. Ltd.	Remedies/preventives for parkinson's disease

2000
- 2000-08-24 US US09/645,127 patent/US6355653B1/en not_active Expired - Fee Related
- 2000-08-28 JP JP2001522222A patent/JP2003528811A/ja active Pending
- 2000-08-28 HU HU0203316A patent/HUP0203316A3/hu unknown
- 2000-08-28 PL PL00354240A patent/PL354240A1/xx not_active Application Discontinuation
- 2000-08-28 YU YU13502A patent/YU13502A/sh unknown
- 2000-08-28 CN CN00812501A patent/CN1379777A/zh active Pending
- 2000-08-28 HR HR20020172A patent/HRP20020172A2/hr not_active Application Discontinuation
- 2000-08-28 EP EP00964043A patent/EP1214322A2/en not_active Withdrawn
- 2000-08-28 MX MXPA02001748A patent/MXPA02001748A/es unknown
- 2000-08-28 CA CA002383998A patent/CA2383998A1/en not_active Abandoned
- 2000-08-28 IL IL14816700A patent/IL148167A0/xx unknown
- 2000-08-28 KR KR1020027002990A patent/KR20020027625A/ko not_active Ceased
- 2000-08-28 AU AU75110/00A patent/AU7511000A/en not_active Abandoned
- 2000-08-28 TR TR2002/00579T patent/TR200200579T2/xx unknown
- 2000-08-28 BR BR0013792-8A patent/BR0013792A/pt not_active IP Right Cessation
- 2000-08-28 CZ CZ20021220A patent/CZ20021220A3/cs unknown
- 2000-08-28 WO PCT/EP2000/008372 patent/WO2001017999A2/en not_active Ceased
- 2000-09-04 AR ARP000104612A patent/AR037484A1/es not_active Application Discontinuation
- 2000-09-04 PE PE2000000903A patent/PE20010629A1/es not_active Application Discontinuation
2002
- 2002-02-06 ZA ZA200201055A patent/ZA200201055B/xx unknown
- 2002-03-05 NO NO20021077A patent/NO20021077L/no not_active Application Discontinuation
- 2002-03-06 MA MA26540A patent/MA26816A1/fr unknown

Also Published As

Publication number	Publication date
WO2001017999A2 (en)	2001-03-15
US6355653B1 (en)	2002-03-12
BR0013792A (pt)	2002-05-14
NO20021077D0 (no)	2002-03-05
MA26816A1 (fr)	2004-12-20
AR037484A1 (es)	2004-11-17
HUP0203316A3 (en)	2004-07-28
HRP20020172A2 (en)	2003-10-31
JP2003528811A (ja)	2003-09-30
IL148167A0 (en)	2002-09-12
AU7511000A (en)	2001-04-10
HUP0203316A2 (hu)	2003-01-28
YU13502A (sh)	2004-11-25
PE20010629A1 (es)	2001-05-30
CZ20021220A3 (cs)	2002-10-16
EP1214322A2 (en)	2002-06-19
TR200200579T2 (tr)	2002-12-23
ZA200201055B (en)	2003-07-30
CN1379777A (zh)	2002-11-13
MXPA02001748A (es)	2002-08-06
PL354240A1 (en)	2003-12-29
CA2383998A1 (en)	2001-03-15
KR20020027625A (ko)	2002-04-13
WO2001017999A3 (en)	2001-12-06

Publication	Publication Date	Title
NO20000885L (no)	2000-08-25	4-Fenyl-pyridin-derivater
NO20021077L (no)	2002-03-05	Amino-triazolopyridin-derivater
ATE263748T1 (de)	2004-04-15	Admantan-derivate
ATE293104T1 (de)	2005-04-15	Thiazolylamid-derivate
IS6128A (is)	2001-10-26	13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da)	2004-12-20	5-phenyl-pyrimidinderivater
ATE338021T1 (de)	2006-09-15	Substituierte 2-dialkylaminoalkylbiphenyl- derivate
NO20021803D0 (no)	2002-04-17	Isoksazolkarboksamid-derivater
PT1237857E (pt)	2004-10-29	Novos derivados fenalquiloxi-fenilo
ATE257148T1 (de)	2004-01-15	Propargyletherderivate
ATE273272T1 (de)	2004-08-15	Mevinolinderivate
ATE374747T1 (de)	2007-10-15	Monofluoralkylderivate
DK1187815T3 (da)	2006-06-19	4-phenyl-pyrimidinderivater
DE60006703D1 (de)	2003-12-24	4-hydroxybiphenylhydrazid-derivate
ATE293592T1 (de)	2005-05-15	Resorcinderivate
TR200002831A3 (tr)	2001-04-20	Kinolin-4-Il türevleri I
DK1189886T3 (da)	2006-05-15	Ethansulfonyl-piperidinderivater
NO20022867D0 (no)	2002-06-14	Syklopentenon-derivater
NO20020212D0 (no)	2002-01-15	3-amino-2-benzyl-1-fenyl-propanderivater
PT1194401E (pt)	2004-02-27	Derivados de diacil-hidrazina
DK1178984T3 (da)	2003-06-10	1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
ATE269328T1 (de)	2004-07-15	1-cycloalkylpyrazolyl-benzoyl-derivate

Legal Events

Date	Code	Title	Description
2005-05-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application